logo

Novartis Ag (NVS)



Trade NVS now with
  Date
  Headline
7/29/2019 1:03:18 AM Novartis Announces Topline Results From Global Phase III PARAGON-HF Study
7/26/2019 8:15:37 AM Novartis Gets Positive CHMP Opinion For Lucentis Treatment In Preterm Infants With ROP
7/22/2019 1:18:27 AM Novartis: Sandoz Announces First Patient Enrolled In Clinical Study For Proposed Biosimilar Denosumab In Osteoporosis
7/19/2019 8:35:35 AM Gilead Sciences Licenses Three Preclinical Antiviral Programs From Novartis
7/18/2019 1:02:49 AM Novartis Q2 EPS From Cont Ops $0.91 Vs $3.32 Last Year
7/16/2019 1:23:44 AM Novartis Says FDA Accepted BLA And Granted Priority Review For SEG101
6/14/2019 2:53:49 AM Novartis Reports Results From Two Phase II Trials, ENESTfreedom And ENESTop